- Home
- WWR vs INO Comparison
WWR vs INO Comparison
Compare WWR & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.89
HOLD
Current Price
$2.23
Company Overview
Basic Information| Metric | WWR | INO |
|---|---|---|
| Founded | 1977 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 136.6M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | WWR | INO |
|---|---|---|
| Price | $0.89 | $2.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $1.88 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21,219.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $1.30 |
| 52 Week High | $3.75 | $4.08 |
Technical Indicators
Market Signals| Indicator | WWR | INO |
|---|---|---|
| Relative Strength Index (RSI) | 42.05 | 58.63 |
| Support Level | $0.95 | $1.86 |
| Resistance Level | $1.09 | $2.27 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 18.19 | 95.12 |
Price Performance
Historical Comparison WWR
INO
About WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.